Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer - Authors' reply. Gronberg BH, Langer SW, Nyman J, Halvorsen TO, et al. Lancet Oncol 2021;22:e222.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gronberg BH, Langer SW, Nyman J, Halvorsen TO, et al. Twice-daily chemoradiotherapy in limited-stage small-cell lung cancer - Authors' reply. Lancet Oncol 2021;22:e222.
PMID: 34087132